April 30, 2016 5:50 AM ET


Company Overview of YM BioSciences USA Inc.

Company Overview

YM BioSciences USA Inc. produces, acquires, and commercializes products for the treatment of cancer, cancer-related disorders, and infectious diseases. Its portfolio includes therapeutic oncology products, including THYMITAQ, a nolatrexed dihydrochloride for the treatment of patients with inoperable primary liver cancer; and ORATAQ, an oral form of nolatrexed. The company was formerly known as EXIMIAS Pharmaceutical Corporation and changed its name to YM BioSciences USA Inc. in May, 2006. The company was founded in 1998 and is based in Winchester, Massachusetts. As of May 9, 2006, YM BioSciences USA Inc. operates as a subsidiary of YM BioSciences Inc.

10 Priscilla Lane

Winchester, MA 01890

United States

Founded in 1998





Key Executives for YM BioSciences USA Inc.

Vice President of Operations
Age: 69
Co-Principal Investigator of ETHECC(C) Trial
Co-Principal Investigator of the ETHECC(C) Trial
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Choice Genetics USA, LLC United States
Americare Health Scan, Inc. United States
CHIP Diagnostics, Inc. United States
ChemoCore Therapeutics, Inc. United States
Royce Laboratories, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact YM BioSciences USA Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.